sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Chemotherapy Induced Peripheral Neuropathy Market Scope And Analysis

  • Report Code : TIPRE00028941
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 151
Buy Now

Chemotherapy Induced Peripheral Neuropathy Market Scope 2031

Buy Now

Chemotherapy Induced Peripheral Neuropathy Market Report Chemotherapy Induced Peripheral Neuropathy Market Size and Share Chemotherapy Induced Peripheral Neuropathy Market Scope and Analysis

Chemotherapy Induced Peripheral Neuropathy Market Report Scope

Report Attribute Details
Market size in 2021 US$ 813.48 Million
Market Size by 2028 US$ 1,174.26 Million
Global CAGR (2021 - 2028) 5.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Drug Class
  • Steroids
  • Antidepressants
  • Anti-Seizure
  • Narcotics
By Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • REGENACY PHARMACEUTICALS INC
  • ASAHI KASEI PHARMA CORPORATION
  • NOVAREMED
  • MAKSCIENTIFIC LLC
  • WEX PHARMACEUTICALS INC
  • SOVA PHARMACEUTICALS INC
  • KINETA INC
  • APTINYX INC
  • APEXIAN PHARMACEUTICALS INC